3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Glioma
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Ependymoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Ureteral Neoplasms
1
Thyroid Nodule
1
Interventions
Specimen Handling
7
Radiotherapy, Intensity-Modulated
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Cisplatin
5
Patient Navigation
3
Methods
3
Early Intervention, Educational
3
Carboplatin
3
human papillomavirus vaccine, L1 type 16, 18
2
epigallocatechin gallate
2
artesunic acid
2
artemisinin
2
Standard of Care
2
Practice Guidelines as Topic
2
Papillomavirus Vaccines
2
Mass Screening
2
Educational Status
2
Docetaxel
2
Cytological Techniques
2
Blood Specimen Collection
2
toripalimab
1
fludarabine phosphate
1
fludarabine
1
artenimol
1
aldesleukin
1
adacel
1
Watchful Waiting
1
Vitamin B 12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Watchful Waiting
×
1 year
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled